American Trade Association for Cannabis & Hemp Responds to HHS Recommendation for Cannabis to be Reclassified as a Schedule III Drug under the Controlled Substances Act
(Washington, D.C.) – Today, the American Trade Association of Cannabis and Hemp (ATACH), released the following statement in response to the announcement that a top official at the Department of Health and Human Services called for cannabis to be reclassified as a Schedule III drug under the Controlled Substances Act. Assistant HHS Secretary for Health Rachel Levine […]